GRI Bio, Inc.
GRI
$1.51
-$0.02-1.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.80% | -20.00% | -72.69% | 10.32% | -38.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.55% | -2.70% | -61.96% | 91.80% | 21.54% |
| Operating Income | 3.55% | 2.70% | 61.96% | -91.80% | -21.54% |
| Income Before Tax | -189.77% | 0.66% | 66.65% | 12.23% | 11.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -189.77% | 0.66% | 66.65% | 12.23% | 11.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -189.77% | 0.66% | 66.65% | 12.23% | 11.68% |
| EBIT | 3.55% | 2.70% | 61.96% | -91.80% | -21.54% |
| EBITDA | 3.56% | 2.70% | 61.98% | -91.89% | -21.55% |
| EPS Basic | 93.40% | 90.41% | 29.83% | 15.15% | 15.95% |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | 86.80% | 90.41% | 29.83% | 15.15% | 15.95% |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 2,612.71% | 927.07% | 48.62% | 3.31% | 13.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |